Active peptic ulcer disease in patients with hepatitis C virus-related cirrhosis: The role of Helicobacter pylori infection and portal hypertensive gastropathy

Canadian Journal of Gastroenterology

Volumn 18, Issue 8, 2004, Pages 521-524

  Dore, Maria Pina ^a   Mura, Daniela ^a   Deledda, Stefania ^a   Maragkoudakis, Emmanouil ^a   Pironti, Antonella ^a   Realdi, Giuseppe ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Cirrhosis; Congestive gastropathy; Helicobacter pylori infection; Portal hypertension

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL VIRULENCE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPEPSIA; ENDOSCOPY; EPIDEMIOLOGICAL DATA; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PEPTIC ULCER; PORTAL HYPERTENSION; PREVALENCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SCREENING TEST; STATISTICAL SIGNIFICANCE; STOMACH DISEASE; UREA BREATH TEST; VIRUS PATHOGENESIS; VIRUS VIRULENCE;

EID: 4544370568     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/150674     Document Type: Article

References (24)

1. Zullo A, Rinaldi V, Meddi P, et al. Helicobacter pylori infection in dyspeptic cirrhotic patients. Hepatogastroenterology 1999;46:395-400.
2. Kitano S, Dolgor B. Does portal hypertension contribute to the pathogenesis of gastric ulcer associated with liver cirrhosis? J Gastroenterol 2000;35:79-86.
3. Chen JJ, Changchien CS, Tai DI, Chiou SS, Lee CM, Kuo CH. Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study. Dig Dis Sci 1994;39:1565-8.
4. Wu CS, Lin CY, Liaw YF. Helicobacter Pylori in cirrhotic patients with peptic ulcer disease: A prospective, case controlled study. Gastrointest Endosc 1995;42:424-7.
5. Tsai CJ. Helicobacter pylori infection 2nd peptic ulcer disease in cirrhosis. Dig Dis Sci 1998;43:1219-25.
6. Calvet X, Navarro M, Gil M, et al. Epidemiology of peptic ulcer disease in cirrhotic patients: Role of Helicobacter pylori infection. Am J Gastroenterol 1998;93:2501-7.
7. Gisbert JP, Moreno-Otero R, Pajares JM. [Prevalence of Helicobacter pylori infection in chronic liver disease and relationship with its complications: Systematic review and meta-analysis.] Med Clin (Barc) 2002;119:464-74. Spanish
8. Vergara M, Calvet X, Roque M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol 2002;14:717-22.
9. Dore MP, Negrini R, Tadeu V, et al. Novel monoclonal antibody-based Helicobacter pylori stool antigen test. Helicobacter 2004;9:228-32.
10. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices: Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988;319:983-9.
11. McCormack TT, Sims J, Eyre-Brook I, et al. Gastric lesions in portal hypertension: Inflammatory gastritis or congestive gastropathy? Gut 1985;26:1226-32.
12. Soll A. Gastric, duodenal and stress ulcer. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease. Philadelphia: Saunders, 1993:580-679.
13. Dagradi AE, Mehler R, Tan DT, Stempien SJ. Sources of upper gastrointestinal bleeding in patients with liver cirrhosis and large esophagogastric varices. Am J Gastroenterol 1970;54:458-63.
14. Bonnevie O. Causes of death in duodenal and gastric ulcer. Gastroenterology 1977;73:1000-4.
15. Dore MP, Piana A, Carta M, et al. Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection. Aliment Phannacol Ther 1998;12:635-9.
16. Realdi G, Dore MP, Piana A, et al. Pretreatment antibiotic resistance in Helicobacter pylori infection: Results of three randomized controlled studies. Helicobacter 1999;4:106-12.
17. Zulto A, Hassan C, Morini S. Helicobacter pylori infection in patients with liver cirrhosis: Facts and fictions. Dig Liver Dis 2003;35:197-205.
18. Siringo S, Vaira D, Menegatti M, et al. High prevalence of Helicobacter pylori in liver cirrhosis: Relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci 1997;42:2024-30.
19. Kirchner GI, Wagner S, Schmidt H, et al. Pathogenetic role of Helicobacter pylori infection in chronic liver disease. Gastroenterology 1996;110:A157. (Abst)
20. Parikh SS, Desai SB, Prabhu SR, et al. Congestive gastropathy: factors influencing development, endoscopic features, Helicobacter pylori infection, and microvessel changes. Am J Gastroenterol 1994;89:1036-42.
21. D'Amico G, Montalbano L, Traina M, et al. Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital. Gastroenterology 1990;99:1558-64.
22. Bahnacy A, Kupcsulik P, Eles Z, Jaray B, Flautner L. Helicobacter pylori infection in congestive gastropathy. Helicobacter 1996;1:168-71.
23. Balan KK, Jones AT, Roberts NB, Pearson JP, Critchley M, Jenkins SA. The effects of Helicobacter pylori colonization on gastric function and the incidence of portal hypertensive gastropathy in patients with cirrhosis of the liver. Am J Gastroenterol 1996;91:1400-6.
24. Gisbert J, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez-Munoz J. H pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev 2004;2:CD004062.